Follow DuPont to never miss an important update.
A federal judge approved a settlement worth more than 2.5 billion dollars to resolve claims in New Jersey over PFAS. These are often called forever chemicals because they do not break down easily in the environment and have been linked to health risks. The settlement is shared between DuPont, 3M, and two other related companies.
For a long-term owner, this is a step toward putting these legacy legal issues in the past. While the total dollar amount is large, it was already expected and agreed upon by the companies involved. Having the court finalize the deal removes the uncertainty of a trial and allows the company to focus on its newer electronics and water businesses.
Source: Reuters
DuPont's water filtration business won a contract to supply its membrane bioreactor system to the Lower Molonglo Water Quality Control Centre in Australia. This facility is the largest inland wastewater treatment plant in the country, and the upgrade will make it the largest plant of its specific type in Australia.
This win supports our view that DuPont is successfully pivoting toward high-growth areas like water scarcity solutions. While the company is often associated with industrial chemicals, these specialized filtration membranes are a more stable and profitable business that helps offset the ups and downs of the electronics market.
Source: PRNewsWire
Federal Reserve officials are weighing whether the rapid pace of investment in AI data centers is becoming excessive. They are concerned that this frenzied spending could create risks for the broader financial system if the expected returns do not materialize.
This matters for DuPont because its electronics business is a major supplier of materials used to make the advanced chips that power AI. If big tech companies pull back on data center spending, it could slow the recovery in chip manufacturing volumes that DuPont is counting on for growth.
Source: Reuters
DuPont won a 2026 R&D 100 Award for its Liveo Pharma TPE tubing, which is designed for biopharmaceutical processing at extremely low temperatures. These awards recognize the top 100 technical innovations of the year. While a single award does not change the company's value, it highlights DuPont's focus on high-margin healthcare materials. This segment is a key part of the company's shift toward specialized chemistry that is difficult for rivals to replicate.
Source: PRNewsWire
The company's specialized water membrane was recognized for helping industrial plants reuse water and recover resources from brine, which is highly salty wastewater. This technology reduces the energy needed for traditional water treatment. Water filtration is one of DuPont's most important growth areas. As global regulations on industrial waste tighten and water becomes scarcer, demand for these high-efficiency membranes provides a steady, less cyclical source of profit compared to the company's older chemical businesses.
Source: PRNewsWire
Management has beaten its own profit targets for eight straight quarters, often by a wide margin. This suggests they are conservative with their forecasts and have a firm handle on their costs.
| Expectation | |
|---|---|
| EPS | $1.87 |
| Revenue | $1.85B |